electroCore Completes $70 Million Series B Funding Round
Investment to fund commercialization of gammaCore® and further clinical development of nVNS
BASKING RIDGE, N.J., Nov. 29, 2017 -- (Healthcare Sales & Marketing Network) -- electroCore, a U.S.-based bioelectronic medicine healthcare company advancin... Devices, Neurology, Venture Capital electroCore, gammaCore, cluster headache, vagus nerve stimulation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Brain | Funding | Headache | Marketing | Migraine | Neurology | Pharmaceuticals | Vagus Nerve Stimulation Therapy | Venture Capital